11th EDRN Scientific Workshop, September 10–12, 2019
(This meeting is not online.)
- Cancer Research UK
- Nanomechanical Fine-needle Sensor for Cancer Detection
- BloodPAC: Establishing Standards to Accelerate Development and Approval of Liquid Biopsy Technology
- Gastrointestinal Cancers: Overview of the Collaborative Group Activities
- Urine Based Molecular Assay for Early Detection of Prostate Cancer in Context of Race
- Consortium for Molecular and Cellular Characterization of Screen Detected Lesions: Overview of Collaborative Projects including Pathology Working Group
- Panel Discussion: Statistical Considerations for Robust, Reproducible Biomarkers
- Genomic Testing for Population Risk Stratification in Breast Cancer
- Pancreatic Cancer Detection Consortium (PCDC)
- Cancer Overdiagnosis: A Biological Challenge and a Clinical Dilemma
- Not All Genomes Falling Apart Lead to Cancer
- Chronic Pancreatitis Diabetes and Pancreatic Cancer Consortium (CPDPC)
- Multi-Modal Methods for Biomarker Discovery in Diseased Lung
- Opening Remarks
- Translational Liver Cancer Consortium (TLC)
- Retrospective Analysis of the Performance of MiPS in Patients Having Had Multi-Parametric MRI
- microRNA Expression Differences in Nasal Epithelium for Identifying Malignant Indeterminate Pulmonary Nodules
- Liquid Biopsies: Beyond Blood
- Early Detection of Pancreatic Cancer: Collaborative Studies Under the EDRN Umbrella
- Breast and Gynecological Cancers: Overview of the Collaborative Group Activities
- NCI-Liquid Biopsy Consortium (NLBC)
- Panel Discussion: Technology and Licensing of Biomarkers from Research Lab to IVD Companies
- Development of the Multi-marker Assay and Algorithm
- Zip File of All 11th EDRN Scientific Workshop Presentations
- Radiomics of Screening: Hope or Hype?
- What's New? FDA IVD Initiatives and Regulations
- Industrial Benchmarks for Biomarkers in Commercialization
- Panel Discussion: BIology of Liquid Biopsy
- Assessing the accuracy of a deep learning method to risk stratify indeterminate pulmonary nodules
- 11th EDRN Scientific Workshop Agenda
- Imaging-related Considerations for Early Detection of Pancreatic Cancer
- A Unique Approach Combining Avatar Mice and Targeted Mass Spectrometry to Identify Blood Biomarkers for Early Detection of Breast Cancer
- Proteomic Tissue Classifier for Early Prediction of Prostate Cancer Progression
- Circular RNA in Cancer Detection
- The Potential for Early Detection of Pancreatic Cancer: The Role of Deep Learning and Radiomics
- Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer
- Developing Knowledge Environments for Consortium-based Clinical Cancer Biomarker Studies
- FDA Regulatory Requirements for Successful Biomarkers Application
- Identification of Aggressive Prostate Cancers: In-depth Proteomics of Tissues and Urines
- Setting up the Bar of Diagnostic Performance: Sensitivity, Spedificity and Predictive Values for Biomarkers
- Lung and Upper Aerodigestive Cancers: Overview of the Collaborative Group Activities
- Lung Cancer Detection
- Illuminating the Tumor Microenvironment: Astronomy Informs Pathology
- Collaborative Project: Circulating Autoantibody Biomarkers for Early Detection of Ovarian Cancer
- Optimizing DNA Methylation Detection for Early Lung Cancer
- CLIA and CAP Requirements for Biomarker Assays (LDT)
- Variability in Tumour Presentation: The Influence of the Germline on Somatic Evolution
- Substantial Reduction in Validation Sample Size with the Opportunity for Second-chance Discovery
- Automated Molecular Diagnosis of Suspicious Breast Lesions in Underdeveloped Countries
- Serum Protein, Urine RNA and Tissue Metabolite Targets to Detect and Image Prostate Cancer
When
- Los Angeles
- Sept. 10, 2019, 5 a.m.
- Denver
- Sept. 10, 2019, 6 a.m.
- Chicago
- Sept. 10, 2019, 7 a.m.
- New York
- Sept. 10, 2019, 8 a.m.
- UTC
- Sept. 10, 2019, noon